Newsletter
Newsletter Support JNS

IRGC officer killed in Syria blast; Iran blames Israel

The officer, identified by an Israeli research organization as Col. Daoud Jaafari, was killed by a roadside bomb; Islamic Revolutionary Guard Corps vows to retaliate.

Shipping containers burn at Syria's Latakia port following what Syrian media claim was an Israeli missile strike, Dec. 7, 2021. Source: Screenshot.
Shipping containers burn at Syria’s Latakia port following what Syrian media claim was an Israeli missile strike, Dec. 7, 2021. Source: Screenshot.

Israel was responsible for the death of a senior Iranian Islamic Revolutionary Guards Corps officer in a roadside bomb blast in Syria on Tuesday, the IRGC said in a statement on Wednesday.

The statement included messages of condolences to the officer’s family, and a vow to retaliate, according to a report by Ynet.

The Alma Center, an Israeli defense research organization, said the officer was at the rank of colonel, adding that he has been identified as Daoud Jaafari.

Jaafari’s was “one of the senior members of the air force of the Revolutionary Guards,” Alma stated in a tweet. “At this stage, it is not clear what his exact position is.”

“It is known that the Iranians have ballistic missiles, UAVs [unmanned aerial vehicles] and air defense arrays deployed and operating in Syria. It is possible that he was involved in the maintenance and operation of one of these arrays. Based on his position, he may have been professionally involved in supervising the transportation of these kinds of weapons to Syria, within Syria, and to Lebanon,” said Alma.

Hamas said it is willing to move forward with second stage of the U.S.-brokered framework, calling on Washington to exert pressure on Jerusalem.
“We can and know how to stand our ground—even against our best friends when necessary,” said Prime Minister Benjamin Netanyahu.
Some 109 votes separate Luc Jasmin III, whose father resigned from a state panel after making antisemitic remarks, and the Republican candidate.
The Tel Aviv-based drug maker is facing an antitrust lawsuit, together with several other pharmaceutical companies.